Sun Pharma eclipsed by 75% fall in Q3 net profit on weak US business – Business Standard


Business Standard

Sun Pharma eclipsed by 75% fall in Q3 net profit on weak US business
Business Standard
A sixteen per cent decline in revenue and a one-off tax expense of Rs 5.13 billion resulted in a 75 per cent fall in Sun Pharmaceutical Industries' consolidated net profit in the third quarter of 2017-18. India's largest drug maker by revenue reported ...
Sun Pharma profit drops 75% on US sales dip, one-time tax write-offMoneycontrol.com
Sun Pharma Q3 profit slides 75% to Rs365 crore on weak US salesLivemint
Sun Pharma reports 75% drop in net profit in Q3Times of India
Economic Times -Business Today -NDTV -Outlook India
all 22 news articles »